Cassell, J. A., Balakrishnan, I., Samarasinghe, D., Mistry, P., Prentice, H.G. and Gillespie, S.H. (1998) RP59500 (quinupristin/dalfopristin): three case reports of its use in infection due to Enterococcus faecium. Journal of Infection, 36 (3). pp. 324-327.Full text not available from this repository.
We describe three cases of Enterococcus faecium sepsis arising in immunocompromised patients, severely ill with other conditions, who were treated with the new injectable streptogramin RP59500. There are still few reports of clinical experience with this drug. All had bacteriological resolution, with one patient recovering fully. Although two of the three patients died, this was due to underlying disease in one case and a Gram-negative superinfection in another. Quinupristin/dalfopristin therapy was not associated with significant adverse effects in any of the patients.
|Additional Information:||TY - JOUR|
|Schools and Departments:||Brighton and Sussex Medical School > Brighton and Sussex Medical School|
|Depositing User:||Jackie Cassell|
|Date Deposited:||30 Mar 2007|
|Last Modified:||30 Nov 2012 16:51|
|Google Scholar:||5 Citations|